Cargando…

The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro

Earlier studies with nanoparticles carrying siRNA were restricted to investigating the inhibition of target-specific protein expression, while almost ignoring effects related to the nanoparticle composition. Here, we demonstrate how the design and surface decoration of nanoparticles impact the p65 n...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Elena K., Białas, Nataniel, Epple, Matthias, Hilger, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313450/
https://www.ncbi.nlm.nih.gov/pubmed/35884877
http://dx.doi.org/10.3390/biomedicines10071571
_version_ 1784754082884354048
author Müller, Elena K.
Białas, Nataniel
Epple, Matthias
Hilger, Ingrid
author_facet Müller, Elena K.
Białas, Nataniel
Epple, Matthias
Hilger, Ingrid
author_sort Müller, Elena K.
collection PubMed
description Earlier studies with nanoparticles carrying siRNA were restricted to investigating the inhibition of target-specific protein expression, while almost ignoring effects related to the nanoparticle composition. Here, we demonstrate how the design and surface decoration of nanoparticles impact the p65 nuclear factor-kappa B (NF-κB) protein expression in inflamed leucocytes and endothelial cells in vitro. We prepared silica-coated calcium phosphate nanoparticles carrying encapsulated siRNA against p65 NF-κB and surface-decorated with peptides or antibodies. We show that RGD-decorated nanoparticles are efficient in down-regulating p65 NF-κB protein expression in endothelial cells as a result of an enhanced specific cellular binding and subsequent uptake of nanoparticles. In contrast, nanoparticles decorated with IgG (whether specific or not for CD69) are efficient in down-regulating p65 NF-κB protein expression in T-cells, but not in B-cells. Thus, an optimized nanoparticle decoration with xenogenic IgG may stimulate a specific cellular uptake. In summary, the composition of siRNA-loaded calcium phosphate nanoparticles can either weaken or stimulate p65 NF-κB protein expression in targeted inflamed leucocytes and endothelial cells. In general, unveiling such interactions may be very useful for the future design of anti-p65 siRNA-based nanomedicines for treatment of inflammation-associated diseases.
format Online
Article
Text
id pubmed-9313450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93134502022-07-26 The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro Müller, Elena K. Białas, Nataniel Epple, Matthias Hilger, Ingrid Biomedicines Article Earlier studies with nanoparticles carrying siRNA were restricted to investigating the inhibition of target-specific protein expression, while almost ignoring effects related to the nanoparticle composition. Here, we demonstrate how the design and surface decoration of nanoparticles impact the p65 nuclear factor-kappa B (NF-κB) protein expression in inflamed leucocytes and endothelial cells in vitro. We prepared silica-coated calcium phosphate nanoparticles carrying encapsulated siRNA against p65 NF-κB and surface-decorated with peptides or antibodies. We show that RGD-decorated nanoparticles are efficient in down-regulating p65 NF-κB protein expression in endothelial cells as a result of an enhanced specific cellular binding and subsequent uptake of nanoparticles. In contrast, nanoparticles decorated with IgG (whether specific or not for CD69) are efficient in down-regulating p65 NF-κB protein expression in T-cells, but not in B-cells. Thus, an optimized nanoparticle decoration with xenogenic IgG may stimulate a specific cellular uptake. In summary, the composition of siRNA-loaded calcium phosphate nanoparticles can either weaken or stimulate p65 NF-κB protein expression in targeted inflamed leucocytes and endothelial cells. In general, unveiling such interactions may be very useful for the future design of anti-p65 siRNA-based nanomedicines for treatment of inflammation-associated diseases. MDPI 2022-07-01 /pmc/articles/PMC9313450/ /pubmed/35884877 http://dx.doi.org/10.3390/biomedicines10071571 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Müller, Elena K.
Białas, Nataniel
Epple, Matthias
Hilger, Ingrid
The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro
title The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro
title_full The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro
title_fullStr The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro
title_full_unstemmed The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro
title_short The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro
title_sort peptide/antibody-based surface decoration of calcium phosphate nanoparticles carrying sirna influences the p65 nf-κb protein expression in inflamed cells in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313450/
https://www.ncbi.nlm.nih.gov/pubmed/35884877
http://dx.doi.org/10.3390/biomedicines10071571
work_keys_str_mv AT mullerelenak thepeptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro
AT białasnataniel thepeptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro
AT epplematthias thepeptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro
AT hilgeringrid thepeptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro
AT mullerelenak peptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro
AT białasnataniel peptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro
AT epplematthias peptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro
AT hilgeringrid peptideantibodybasedsurfacedecorationofcalciumphosphatenanoparticlescarryingsirnainfluencesthep65nfkbproteinexpressionininflamedcellsinvitro